The levodopa equivalent dose was higher in the PD group (363.9 ± 220.3 mg) compared to the SCA3 group (144.4 ± 121.0 mg) (P < 0.05 by unpaired t-test). This evidence concerns the gene ATXN3 and Parkinson disease.